Please allow up to 24 hours for tracking information to become active
New Canadian research has provided further evidence linking the use of GLP-1 agonists (such as weight loss drugs like Ozempic and Wegovy) with an increased risk for serious gastrointestinal issues including stomach paralysis, pancreatitis and bowel obstruction
Teichman et al., Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults, 91(3):799-805, Epub 2005 Dec 13
A clinician may adjust the dose based on response, side effects, and medical judgment
In some cases, Ozempic is prescribed off-label for weight management, though this isnt likely
Research shows they can lead to weight loss of about 10.5 to 15.8 pounds